Literature DB >> 9276537

Characterization of complement C6 deficiency in a PVG/c rat strain.

M G van Dixhoorn1, J J Timmerman, D J Van Gijlswijk-Janssen, Y Muizert, C Verweij, R G Discipio, M R Daha.   

Abstract

Complement C6 plays an important role in the effector phase of complement-mediated cell lysis. Recently, a PVG/c rat strain deficient in haemolytic C6 activity was discovered. In the present study we show that these rats lack both antigenic and functional C6, and that repetitive immunization of these rats with PVG/c+ serum results in generation of specific anti-rat C6 antibodies. The observed absence of rat C6 was further investigated at the genomic and transcriptional level using a 492-bp cDNA of rat C6, cloned from a rat liver cDNA library using full length human C6 as a probe. Northern blot analysis revealed the presence of C6 mRNA in livers of both PVG/c- and PVG/c+ rats, corresponding to a size of approximately 3.3 kb, although the level of C6 mRNA expression was approximately 100-fold less in PVG/c- rats. In addition, using rat C6-specific primers, positive signals were obtained in kidneys of both rat strains by reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. Southern blot analysis of digested genomic DNA did not reveal evidence for large C6 gene deletions. We conclude that the lack of C6 protein in the PVG/c- rat strain is not due to a (large) C6 gene deletion, but presumably is caused by an unstable mRNA or a point mutation in the C6 gene resulting in an aberrant transcription of the C6 gene. Alternatively, a gene coding for a product involved in C6 biosynthesis that acts in trans may carry a mutation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276537      PMCID: PMC1904735          DOI: 10.1046/j.1365-2249.1997.4551354.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  8 in total

1.  Distinctive roles of neutrophils and monocytes in anti-thy-1 nephritis.

Authors:  R Westerhuis; S C van Straaten; M G van Dixhoorn; N van Rooijen; N A Verhagen; C D Dijkstra; E de Heer; M R Daha
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 2.  Animal models of inherited complement deficiency.

Authors:  S Linton
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

3.  C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuria.

Authors:  Gopala K Rangan
Journal:  World J Nephrol       Date:  2016-05-06

4.  Endotoxin-induced lung inflammation is independent of the complement membrane attack complex.

Authors:  R B Brauer; C Gegenfurtner; B Neumann; M Stadler; C D Heidecke; B Holzmann
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  Role of Complement in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy.

Authors:  Jijun Xu; Lingjun Zhang; Mian Xie; Yan Li; Ping Huang; Thomas L Saunders; David A Fox; Richard Rosenquist; Feng Lin
Journal:  J Immunol       Date:  2018-04-25       Impact factor: 5.422

6.  Microbial Neuraminidase Induces a Moderate and Transient Myelin Vacuolation Independent of Complement System Activation.

Authors:  Pablo Granados-Durán; María Dolores López-Ávalos; Manuel Cifuentes; Margarita Pérez-Martín; María Del Mar Fernández-Arjona; Timothy R Hughes; Krista Johnson; B Paul Morgan; Pedro Fernández-Llebrez; Jesús M Grondona
Journal:  Front Neurol       Date:  2017-03-07       Impact factor: 4.003

7.  Complement system activation contributes to the ependymal damage induced by microbial neuraminidase.

Authors:  Pablo Granados-Durán; María Dolores López-Ávalos; Timothy R Hughes; Krista Johnson; B Paul Morgan; Paul P Tamburini; Pedro Fernández-Llebrez; Jesús M Grondona
Journal:  J Neuroinflammation       Date:  2016-05-21       Impact factor: 8.322

8.  Complement C6 deficiency exacerbates pathophysiology after spinal cord injury.

Authors:  Diane Su; Mitra J Hooshmand; Manuel D Galvan; Rebecca A Nishi; Brian J Cummings; Aileen J Anderson
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.